TOP1 and cancer: Camptothecin (CPT) derivatives, for example, topotecan and irinotecan specifically inhibit Topoisomerase 1 (TOP1) and are clinically approved chemotherapeutics for a wide array of cancers including ovarian, colorectal and lung cancers (Thomas & Pommier, 2019).